Company Filing History:
Years Active: 2014
Title: Young Jae Eu: Innovator in Omega Conotoxins
Introduction
Young Jae Eu is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of novel conotoxins. His work focuses on enhancing the binding properties of these toxins to calcium channels, which has important implications for pharmaceutical applications.
Latest Patents
Young Jae Eu holds a patent related to omega conotoxins. The patent describes a method for increasing the binding reversibility of a ω-conotoxin to an N-type calcium channel. This involves preparing a ω-conotoxin with specific amino acid residues that enhance its binding properties. The invention not only introduces a novel ω-conotoxin but also presents a pharmaceutical composition with improved blocking activity and specificity towards N-type calcium channels.
Career Highlights
Throughout his career, Young Jae Eu has been associated with Anygen Co., Ltd., where he has contributed to various research projects. His innovative approach to biochemistry has led to advancements in the understanding of calcium channel interactions. His work is recognized for its potential impact on drug development and therapeutic applications.
Collaborations
Young Jae Eu has collaborated with notable colleagues, including Jae Ii Kim and Hye Whon Rhim. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Young Jae Eu's contributions to the field of biochemistry, particularly through his patent on omega conotoxins, highlight his role as an influential inventor. His work continues to pave the way for advancements in pharmaceutical science.